Glofitamab for Relapsed/Refractory Large B-cell Lymphomas | Joshua Brody, MD | #ASH24

(3:26)

Joshua Brody, MD - Promising New Cancer Vaccine

(1:6)

Low-Grade Lymphomas: Dr. Joshua Brody on Treatments, Strategies, and Innovations

(31:25)

Joshua Brody on Epcoritamab Immunotherapy for DLBCL | ASCO 2024

(3:13)

Dr Josh Brody’s mission to CURE FL

(5:51)

Lymphoma Immunotherapy featuring Dr. Joshua Brody | The Immunology Podcast

(1:3:53)

We're Back

(18:49)

The genius of Josh Homme’s ‘drunken stumble’ technique

(14:21)

Update on Hodgkin Lymphoma | LRF Webinars

(1:2)

Denver vs Cornell | 2025 Men's Lacrosse Highlights

(16:18)

Is Ultimate Spider-Man the Most Underrated Spidey Game? - Mad Panic Gaming

(13:40)

Active monitoring for follicular lymphoma: Louize's Story

(7:45)

Leukaemoid Reaction (HD)

(11:11)

Immunotherapy

(3:10)

2025 NASCAR Stop Motion: Darlington // SMCS S3R6

(13:17)

FirstThought Focus: BiTEs vs. CARs with Dr. Joshua Brody

(59:32)

Dr. Joshua Brody - ASCO 2021

(3:18)

Dr. Brody on Modulating Fas Signaling to Prevent Relapse in Hematologic Malignancies

(1:47)

Dr. Brody Discusses Exciting Therapies for Lymphomas and CLL

(58)

Dr. Brody on Addressing Resistance to Immunotherapy in Non-Hodgkin Lymphoma

(1:16)

RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Mana...

(1:50)

The prevention of antigen escape in B-cell lymphomas treated with bispecific antibodies

(3:15)

Impact of TMTV on PFS following glofitamab treatment in R/R DLBCL

(2:21)

Dr. Brody on In Situ Vaccinations for Cancer

(1:12)

Immunotherapy Treatments B-Cell Non-Hodgkin's: Bispecific Antibodies - Blood Cancer Video Library

(4:53)

Are vaccines dead in lymphoma and CLL?

(2:44)

Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with NHL and CLL

(59:33)

Maintenance Therapy Outcomes in Follicular Lymphoma

(5:45)

Emerging Immunotherapy Treatments for B-Cell Non-Hodgkin's Lymphoma: CAR-T Cells

(9:36)